SIRT1 promotes endometrial tumor growth by targeting SREBP1 and lipogenesis

Oncology Reports

Volumn 32, Issue 6, 2014, Pages 2831-2835

  Lin, Li ^a,b   Zheng, Xiaoxia ^c   Qiu, Chunping ^a   Dongol, Samina ^a   Lv, Qingtao ^d   Jiang, Jie ^a   Kong, Beihua ^a   Wang, Chenguang ^e  

^a SHANDONG UNIVERSITY   (China)

^b LIAOCHENG PEOPLE'S HOSPITAL   (China)

^c JINAN MATERNITY AND CHILD CARE HOSPITAL   (China)

^d SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Endometrial cancer; SIRT1; SREBP1

Indexed keywords

MESSENGER RNA; SIRTUIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SIRT1 PROTEIN, HUMAN; SREBF1 PROTEIN, HUMAN;

ARTICLE; CANCER GROWTH; CANCER TISSUE; CARCINOMA CELL; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOGENESIS; MAJOR CLINICAL STUDY; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UPREGULATION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BIOSYNTHESIS; ENDOMETRIUM TUMOR; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPOGENESIS; RNA INTERFERENCE; SIRTUIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 84914695549     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3521     Document Type: Article

References (38)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin 63: 11-30, 2013.
2. Modesitt SC, Hsu JY, Chowbina SR, Lawrence RT and Hoehn KL: Not all fat is equal: differential gene expression and potential therapeutic targets in subcutaneous adipose, visceral adipose, and endometrium of obese women with and without endometrial cancer. Int J Gycecol Cancer 22: 732-741, 2012.
3. Santos CR and Schulze A: Lipid metabolism in cancer. FEBS J 279: 2610-2623, 2012.
4. Imai S: The molecular mechanism of aging and longevity and the function of Sir2 proteins. Nihon Ronen Igakkai Zasshi 38: 735-739, 2001 (In Japanese).
5. Liu T, Liu PY and Marshall GM: The critical role of the class III histone deacetylase SIRT1 in cancer. Cancer Res 69: 1702-1705, 2009
6. Katto J, Engel N, Abbas W, Herbein G and Mahlknecht U: Tran scription factor NFκB regulates the expression of the histone deacetylase SIRT1. Clin Epigenetics 5: e11, 2013.
7. Song NY and Surh YJ: Janus-faced role of SIRT1 in tumorigenesis. Ann NY Acad Sci 1271: 10-19, 2012.
8. Fang Y and Nicholl MB: Sirtuin 1 in malignant transformation: friend or foe? Cancer Lett 306: 10-14, 2011.
9. Shimano H: SREBPs: physiology and pathophysiology of the SREBP family. FEBS J 276: 616-621, 2009.
10. Swinnen J V, Brusselmans K and Verhoeven G: Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care 9: 358-365, 2006.
11. Menendez JA and Lupu R: Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7: 763-777, 2007.
12. Li JN, Mahmoud MA, Han WF, Ripple M and Pizer ES: Sterol regulatory element-binding protein-1 participates in the regulation of fatty acid synthase expression in colorectal neoplasia. Exp Cell Res 261: 159-165, 2000.
13. Swinnen JV: Increased lipogenesis in steroid-responsive cancer cells: mechanisms of regulation, role in cancer cell biology and perspectives on clinical applications. Verh K Acad Geneeskd Belg 63: 321-333, 2001.
14. Yang YU, Morin PJ, Han WF, et al: Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c. Exp Cell Res 282: 132-137, 2003.
15. Yahagi N, Shimano H, Hasegawa K, et al: Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. Eur J Cancer 41: 1316-1322, 2005.
16. Li W, Tai Y, Zhou J, et al: Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis. Cell Cycle 11: 2348-2358, 2012.
17. Nie LY, Lu QT, Li WH, et al: Sterol regulatory element-binding protein 1 is required for ovarian tumor growth. Oncol Rep 30: 1346-1354, 2013.
18. Eberhard Y, Gronda M, Hurren R, et al: Inhibition of SREBP1 sensitizes cells to death ligands. Oncotarget 2: 186-196, 2011.
19. Huffman DM, Grizzle WE, Bamman MM, et al: SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res 67: 6612-6618, 2007.
20. Choi HN, Bae JS, Jamiyandorj U, et al: Expression and role of SIRT1 in hepatocellular carcinoma. Oncol Rep 26: 503-510, 2011.
21. Kalle AM, Mallika A, Badiger J, Alinakhi and Talukdar P and Sachchidanand: Inhibition of SIRT1 by a small molecule induces apoptosis in breast cancer cells. Biochem Biophys Res Commun 401: 13-19, 2010.
22. Cha EJ, Noh SJ, Kwon KS, et al: Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma. Clin Cancer Res 15: 4453-4459, 2009.
23. Zhao G, Cui J, Zhang JG, et al: SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells. Gene Ther 18: 920-928, 2011.
24. Nakane K, Fujita Y, Terazawa R, et al: Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer Du145 cells. Int J Urol 19: 71-79, 2012.
25. Firestein R, Blander G, Michan S, et al: The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One 3: e2020, 2008.
26. Lai CC, Lin PM, Lin SF, et al: Altered expression of SIRT gene family in head and neck squamous cell carcinoma. Tumour Biol 34: 1847-1854, 2013.
27. Medes G, Thomas A and Weinhouse S: Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res 13: 27-29, 1953.
28. Knight JR and Milner J: SIRT1, metabolism and cancer. Curr Opin Oncol 24: 68-75, 2012.
29. Eberlé D, Hegarty B, Bossard P, Ferré P and Foufelle F: SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86: 839-848, 2004.
30. Bengoechea-Alonso MT, Punga T and Ericsson J: Hyperphosphorylation regulates the activity of SREBP1 during mitosis. Proc Natl Acad Sci USA 102: 11681-11686, 2005.
31. Ponugoti B, Kim DH, Xiao Z, et al: SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J Biol Chem 285: 33959-33970, 2010.
32. Walker AK, Yang F, Jiang K, et al: Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes Dev 24: 1403-1417, 2010.
33. Defour A, Dessalle K, Castro Perez A, et al: Sirtuin 1 regulates SREBP-1c expression in a LXR-dependent manner in skeletal muscle. PLoS One 7: e43490, 2012.
34. Deng X, Zhang W, O-Sullivan I, et al: FoxO1 inhibits sterol regulatory element-binding protein-1c (SREBP-1c) gene expression via transcription factors Sp1 and SREBP-1c. J Biol Chem 287: 20132-20143, 2012.
35. Zhang W, Patil S, Chauhan B, et al: FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem 281: 10105-10117, 2006.
36. Motta MC, Divecha N, Lemieux M, et al: Mammalian SIRT1 represses forkhead transcription factors. Cell 116: 551-563, 2004.
37. Yang Y, Hou H, Haller EM, Nicosia SV and Bai W: Suppression of FOXO1 activity by FhL2 through SIRT1-mediated deacetylation. EmBO J 24: 1021-1032, 2005.
38. Frampton G, Ueno Y, Quinn M, et al: The novel growth factor, progranulin, stimulates mouse cholangiocyte proliferation via sirtuin-1-mediated inactivation of FOXO1. Am J Physiol Gastrointest Liver Physiol 303: G1202-G1211, 2012.